Patients undergoing transplantation of the bone marrow and experiencing development of rashes on a regular basis can benefit from a simple blood test that can solve a treatment-based issue presently faced by doctors.
James Ferrara, M.D., Ruth Heyn Endowed Professor of Pediatrics and Communicable Diseases and director of the bone marrow [...]
August 11, 2010 | Posted in
Steroids Blog |
Read More »
Children suffering from severe treatment resistant graft vs. host disease (GvHD) can expect considerable relief coming their way when Prochymal is administered to them. This finding was reported by Osiris Therapeutics, Inc. (NASDAQ:OSIR) on the basis of a new study.
It was noted that Prochymal use leads to an overall response rate of 63 percent when [...]
March 17, 2010 | Posted in
Steroids Blog |
Read More »
The first biomarker of graft-versus-host disease (GVHD) of the skin has been discovered by researchers at the University of Michigan.
This discovery makes it possible for a simple blood test to solve a treatment dilemma faced by doctors to treat patients who usually develop rashes after bone marrow transplantation.
From Sciencedaily.com:
Rashes are very common in patients after [...]
February 28, 2010 | Posted in
Steroids Blog |
Read More »